Merck & Co. Inc.

NYS: MRK
Pharmaceuticals
Keniworth NJ
Title 1Chairman; President
Executive 1Mr. Kenneth C. Frazier, Chairman; President | Chairman; President
2015 Revenue (US$ Millions)$39,498
2014 Revenue (US$ Millions)$42,237
Revenue Growth (%)-6.48%
Net Income (US$ Millions)$4,442
Common Shares Outstanding (Millions)$2,781
Earnings Per Share (US$)$1.56
Price To Earnings Ratio39.89
Total Equity (US$ Millions)$44,676
Return On Equity (%)9.13%
Long Term Debt (US$ Millions)$23,929
Debt To Equity Ratio (%)0.54%
Market Capitalization (US$ Millions)$146,899
Total Assets (US$ Millions)$101,779
Current Assets (US$ Millions)$29,764
Inventories (US$ Millions)$4,700
Current Liabilities (US$ Millions)$19,203
Cost of Goods Sold (US$ Millions)$14,934
Asset Turnover0.39
Inventory Turnover2.91